Crowdmark, a graduate of the University of Toronto Early-Stage Technology (UTEST) program’s first cohort, was the focus of a February 17 article by Ivor Tossell, The Globe and Mail‘s technology culture columnist.
Dr. James Colliander, co-founder and CEO of Crowdmark.
Created by U of T professor James Colliander, Crowdmark allows educators to quickly and efficiently grade large amounts of tests and exams. Tossell highlighted Crowdmark’s innovation and ease-of-use for the grader. The product is cloud-based, meaning that a team of educators marking the same group of exams don’t have to be in the same room at the same time. Instead, grading can be done remotely.
Tossell spoke with Colliander and Lyssa Neel, Crowdmark’s chief operating officer and a former MI project manager. Here’s an excerpt from the article:
James Colliander, a professor at the University of Toronto, found himself staring at about 5,000 pages of papers from a national math exam. Traditionally, a cadre of markers would sit around a large table for marathon grading sessions, assembly line style, each one tackling the answer to one question before passing it on to the next marker.
Mr. Colliander hacked together an expedient: He scanned the pages into a software framework and distributed them to markers digitally. He was essentially able to parallelize the marking process.
Dr. Lyssa Neel, COO of Crowdmark and former MI project manager.
“The markers didn’t all have to be in the same place, so they could move much faster,” says Lyssa Neel, COO of Crowdmark, the company that, with Mr. Colliander as CEO, has brought the idea to market.
Crowdmark is an online service that takes the idea of distributed marking and scales it to an institutional level.
Dr. Andrew (Andy) Sinclair, OtoSim’s CEO, was interviewed by PharmaBoadroom.com on October 10, 2013 to discuss the company’s success and plans for the future. OtoSim's otoscopy training device is revolutionizing…
MaRS Innovation’s commercialization process helps inventors move their transformational ideas from the lab bench to the market.
Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada announced new collaborations with two Canadian early-stage drug technology development centres, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.
Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.
Together, their technology will work across web and mobile devices to help healthcare organizations work with, share and collaborate using information.
Invented at Toronto’s Mount Sinai Hospital in the IT Department, VitalHub was created to effectively manage patient data through a platform allowing clinicians to rapidly access comprehensive, relevant patient information gathered from multiple disparate clinical information systems.
The VitalHub Server platform sits on top of whatever clinical enterprise systems the hospital, community physician practice or healthcare organization already has in place.
Crowdmark, a graduate of the University of Toronto Early-Stage Technology (UTEST) program’s first cohort, was the focus of a February 17 article by Ivor Tossell, The Globe and Mail‘s technology culture columnist.
